Skip to main content
  • Bookmarks
  • Register
  • Login

NIH OIR/OTT Logo

Main Menu

  • Partnerships

    Partnerships

    These links provide access to the information that is commonly needed for companies or organizations interested in partnering with NIH. The information here covers the process from researching available technologies through fees associated.

    • Overview
    • Opportunities
    • Featured Technologies
    • Collaboration / CRADAs
    • Licensing Process
    • Forms / Model Agreements
    • Startups
    • Non-Profits
    • License Materials
    • Licensing FAQs
    • Business Opportunities
    • Product Showcase
    • Product Pipeline
    • Federal Register Notices

    The NIH cannot commercialize its discoveries even with its considerable size and resources — it relies instead upon partners. Typically, a royalty-bearing exclusive license agreement with the right to sublicense is given to a company from NIH to use patents, materials, or other assets to bring a therapeutic or vaccine product concept to market.

  • Royalties

    Royalties

    Information for inventors and licensees on the administration of royalties.

    • Information for NIH Inventors
    • Information for Licensees
    • License Notices / Reports
    • Royalty Coordinators
    • NIH Payment Center
    • CDC Payment Center

    Each year, hundreds of new inventions are made at NIH and CDC laboratories. Nine NIH Institutes or Centers (ICs) transfer NIH and CDC inventions through licenses to the private sector for further research and development and eventual commercialization.

  • Reports

    Reports

    These links provide access to reports tracking the success of NIH licensed products.

    • Annual Reports
    • Tech Transfer Statistics
    • Tech Transfer Metrics
    • Commercial Outcomes
    • HHS License-Based Vaccines & Therapeutics
    • Public Health & Economic Impact Study
    • Stories of Discovery
    • Chen Lecture Videos
    • NIH Patents and Active Patent Commercialization Licenses
    • Media Room
    • Tech Transfer Newsletters
    • NIH Patents and Patent Applications

    The NIH, CDC and FDA Intramural Research Programs are exceptionally innovative as exemplified by the many products currently on the market that benefit the public every day. Reports are generated from the commonly tracked metrics related to these products.

  • Resources

    Resources

    These links provide resources to those interested in the technology transfer activities at NIH.

    • Forms and Model Agreements
    • License Notices / Reports
    • Video Library
    • Inventor Resources
    • Presentations & Articles
    • FAQs
    • RSS Feeds
    • Inventor Showcase

    Past videos, lectures, presentations, and articles related to technology transfer at NIH are kept and made available to the public. These topics range from general technology transfer information to processes specific to NIH.

  • Policy & Regulations

    Policies & Regulations

    These links provide access to the policies and regulations surrounding partnering or collaborating with NIH.

    • Freedom of Information Act (FOIA)
    • PHS Technology Transfer Policy
    • Policies & Reports
    • Useful Links

    If a company would like to acquire rights to use or commercialize either an unpatented material, or a patented or patent-pending invention, a license is required. There are numerous policies and regulations surrounding the transfer or a technology from the NIH to a company or organization.

  • About

    About Us

    These links provide information about the Office of Technology Transfer.

    • Contact Us
    • Staff Directory
    • Management
    • FAQs
    • HHS Tech Transfer Offices & Contacts
    • Careers in Tech Transfer
    • Location & Directions
    • Feedback

    The NIH Office of Technology Transfer (OTT) plays a strategic role by supporting the patenting and licensing efforts of our NIH ICs. OTT protects, monitors, markets and manages the wide range of NIH discoveries, inventions, and other intellectual property as mandated by the Federal Technology Transfer Act and related legislation.

Breadcrumb

  1. Home
  2. Taxonomy
  3. Term
  4. NCATS

Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders

  • Read more about Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders
Canada
3074110
Filed on 2018-08-28

Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders

  • Read more about Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders
Brazil
BR112020004116-5
Filed on 2018-08-28

Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders

  • Read more about Novel Gamma Aminobutynic Acid Type A Receptor Modulators for Mood Disorders
European Patent
18852438.3
Filed on 2018-08-28

SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDEDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS

  • Read more about SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDEDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS
US Patent 11,505,559
Filed on 2020-04-29

SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS

  • Read more about SUBSTITUTED QUINOLINE ANALOGS AS ALDEHYDE DEHYDROGENASE 1A1 (ALDH1A1) INHIBITORS
European Patent
18804792.2
Filed on 2018-10-30

Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders

  • Read more about Deuterated Alpha5 Subunit-selective Negative Allosteric Modulators Of Gamma-Aminobutyric Acid Type A Receptors As Fast Acting Treatments For Depression And Mood Disorders
US Patent 11,459,320
Filed on 2018-08-28

TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS

  • Read more about TREATMENT FOR WOLFRAM SYNDROME AND OTHER ENDOPLASMIC RETICULUM STRESS DISORDERS
US Patent 11,426,415
Filed on 2018-03-06

Crystal Forms Of An ALK2 Inhibitor

  • Read more about Crystal Forms Of An ALK2 Inhibitor
Patent Cooperation Treaty
PCT/US2019/058062
Filed on 2019-10-25

Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling

  • Read more about Novel ALK2 Inhibitors And Methods For Inhibiting BMP Signaling
Japan
2019-558704
Filed on 2018-04-26

Compounds for Improving MRNA Splicing

  • Read more about Compounds for Improving MRNA Splicing
Brazil
BR112017015019-0
Filed on 2016-01-15

Pagination

  • First page « First
  • Previous page ‹‹
  • …
  • Page 66
  • Page 67
  • Page 68
  • Page 69
  • Page 70
  • Page 71
  • Page 72
  • Page 73
  • Page 74
  • …
  • Next page ››
  • Last page Last »
Subscribe to NCATS
NIH White Technology Transfer Logo

Return to Top

  • About
  • Privacy Notice
  • Accessibility
  • Web Policies & Notices
  • Open Data
  •  
  • For NIH Staff Only
  • HHS
  • NIH
  • HHS Vulnerability Disclosure
  • Connect
  • Twitter
  • LinkedIn
  • Contact
  • Feedback

Office of Technology Transfer, Office of Intramural Research, National Institutes of Health